000 02653na a2200325 4500
003 PC6745
005 20210702062659.0
008 130622s2012 xxx||||| |||| 00| 0 eng d
040 _cH12O
041 _aeng
100 _aFiorante, Silvana
_91609
_eMedicina Interna
100 _aLlenas García, Jara
_91610
_eMedicina Interna
100 _aMaseda Fernández, Diego
_91595
_eMedicina Interna
100 _aMatarranz del Amo, Mariano
_91988
_eMedicina Interna
100 _91026
_aPulido Ortega, Federico
_eUnidad VIH
100 _aRodríguez, Violeta
_92124
_eMedicina Interna
100 _91500
_aRubio García, Rafael
_eUnidad de VIH
100 _aSalto, Efren
_92123
_eMedicina Interna
245 0 0 _aShould We Look for Strongyloides Stercoralis in Foreign-Born HIV-Infected Persons?.
_h[artículo]
260 _aJournal of Immigrant and Minority Health,
_c2012
300 _a15(4):796-802.
500 _aFormato Vancouver: Llenas-García J, Fiorante S, Salto E, Maseda D, Rodríguez V, Matarranz M, Hernando A, Rubio R, Pulido F. Should we look for Strongyloides stercoralis in foreign-born HIV-infected persons? J Immigr Minor Health. 2013 Aug;15(4):796-802.
501 _aPMID: 23233123
504 _aContiene 39 referencias
520 _aThe objective was to evaluate the implementation of a systematic Strongyloides stercoralis screening programme in HIV infected immigrants attending an HIV Unit in Spain. An enzyme-linked immunosorbent assay (ELISA) was performed to assess the presence of Strongyloides IgG. Patients with a positive serology were treated with ivermectin; serologic follow-up testing was performed. 237 patients were screened (65.4 % men). Origin: 64.1 % came from Latin America, 16.5 % from Sub-Saharan Africa, 9.7 % from the Caribbean, 9.7 % from other areas. Strongyloides stercolaris IgG was positive in 13 cases (5.5 %). In the multivariate analysis, factors associated with a positive Strongyloides serology were illiteracy (OR: 23.31; p = 0.009) and eosinophilia (OR: 15.44; p < 0.0001). Nine of the 13 patients positive for S. stercoralis IgG and treated with ivermectin had a follow up serologic test: 77.8 % achieved a serologic response (55.5 % seroreversion). Screening of HIV-positive immigrants may be desirable, at least in those with higher risk of hyperinfection syndrome. Serologic testing seems a useful tool in both diagnosis and follow-up of these patients.
710 _96
_aServicio de Medicina Interna
710 _9625
_aInstituto de Investigación imas12
856 _uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/6/pc6745.pdf
_ySolicitar documento
942 _n0
_2ddc
_cART
999 _c6745
_d6745